Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02034006
Brief Title: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. (OLIMPIC)

First Submitted : January 9, 2014
First Submitted that Met QC Criteria : January 9, 2014
First Posted : January 13, 2014 (Estimate)

Results First Submitted : July 11, 2017
Results First Submitted that Met QC Criteria : October 8, 2018
Results First Posted : February 18, 2019

Last Update Submitted that Met QC Criteria : October 8, 2018
Last Update Posted : February 18, 2019